organophosphonates has been researched along with Fibroma, Shope in 85 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (10.59) | 18.2507 |
2000's | 46 (54.12) | 29.6817 |
2010's | 29 (34.12) | 24.3611 |
2020's | 1 (1.18) | 2.80 |
Authors | Studies |
---|---|
Gündoğdu, Y; Gür, H; Kartı, SS; Koşan, B; Okuturlar, Y; Uzay, A; Yetiş, T | 1 |
Arora, R; Garg, A; Gupta, M; Gupta, N; Singh, M | 1 |
Bibee, K; Cuda, JD; Erdag, G; Girardi, N; Loss, MJ; Orens, JB; Prono, MD; Rangwala, S; Smith, SDB; Toptan, T | 1 |
Cheng, WS; Foster, JH; Krance, R; Martinez, C; Nguyen, NY | 1 |
Krüger, W; Neumann, T; Schmidt, CA; Schneidewind, L | 1 |
DeVos, JM; Gaber, AO; Gaber, LW; Knight, RJ; Moore, LW; Patel, SJ | 1 |
Akbaş, SH; Akkaya, B; Akman, S; Cağla Doğan, S; Colak, D; Comak, E; Dinçkan, A; Koyun, M; Mutlu, D; Mutlu, E; Sağlık, I; Süleymanlar, G; Uslu Gökçeoğlu, A | 1 |
Andrei, G; Coen, N; Duraffour, S; Krecmerová, M; Naesens, L; Snoeck, R; Van den Oord, J | 1 |
Cho, B; Chung, NG; Kang, JH; Kim, HK; Kwon, HJ; Lee, JW | 1 |
Chittick, P; Ohl, CA; Williamson, JC | 1 |
Ader, F; Barraco, F; Billaud, G; Chidiac, C; Detrait, M; Ducastelle-Leprêtre, S; Ferry, T; Gilis, L; Labussière-Wallet, H; Michallet, M; Morisset, S; Nicolini, FE; Salles, G; Sobh, M; Tedone, N; Thomas, X | 1 |
Balogh, KK; Christensen, ND; Cladel, NM; Hu, J | 1 |
DeVos, JM; Gaber, AO; Gaber, LW; Knight, RJ; Kuten, SA; Patel, SJ | 1 |
Boruchov, AM; Chittick, G; Glezerman, IG; Lee, YJ; Momméja-Marin, H; Papanicolaou, GA; Seshan, SV; Young, JW | 1 |
Ahn, JS; Ahn, SY; Jang, HC; Jang, MO; Jung, SH; Kang, SJ; Kim, HJ; Kim, JY; Kim, YK; Lee, JJ; Lee, SS; Yang, DH | 1 |
Ader, F; Barraco, F; Ducastelle-Leprêtre, S; Gilis, L; Labussiere-Wallet, H; Lebras, L; Michallet, M; Nicolini, FE; Philippe, M; Ranchon, F; Rioufol, C; Salles, G; Schwiertz, V; Thomas, X; Vantard, N; Wattel, E | 1 |
Astor, BC; Djamali, A; Mandelbrot, D; Mohamed, M; Muth, B; Panzer, SE; Parajuli, S; Zhong, W | 1 |
Gill, JS; Wright, AJ | 1 |
Choi, Y; Jeong, J; Jun, JB; Jung, J; Kim, H; Lee, SH | 1 |
Battistelli, S; Benedetti, S; Catalani, S; Galati, R; Nuvoli, B; Palma, F | 1 |
Benedetti, E; Ceccherini-Nelli, L; Focosi, D; Galimberti, S; Maggi, F; Papineschi, F; Petrini, M; Pistolesi, D | 1 |
Casier, S; Filler, G; Grimmer, J; Moussa, M; Rehman, F; Sharma, AP | 1 |
Bernal, G; Cabello, V; Díaz Pedrero, M; Gentil, MA; Margarit, N; Pereira, P | 1 |
Bammens, B; Claes, K; Evenepoel, P; Kuypers, DR; Lerut, E; Vanrenterghem, Y | 1 |
Castagnola, E; Cirillo, C; Cuzzubbo, D; Dallorso, S; Di Marco, E; Faraci, M; Lanino, E; Moroni, C; Morreale, G | 1 |
Chang, HR; Lian, JD; Wu, SW | 1 |
Jordan, SC; Smith, JM | 1 |
Erard, V; Lamoth, F; Meylan, P; Nseir, G; Pascual, M; Venetz, JP | 1 |
Coremans, G; Snoeck, R | 1 |
Baltadakis, I; Beltrame, A; Caniglia, M; Cesaro, S; Dalle, JH; Einsele, H; Faraci, M; Fauser, AA; Heinz, W; Hirsch, HH; Koc, Y; Lopez-Corral, L; Michallet, M; Neuburger, S; Owoc-Lempach, J; Rascon, J; Styczynski, J; Tendas, A; Toporski, J; Tridello, G; Yesilipek, MA | 1 |
Alfieri, C; Bove, P; De Angelis, G; Gallucci, C; Gaziev, J; Germani, S; Isgrò, A; Lucarelli, G; Marziali, M; Miano, R; Paba, P; Paciaroni, K; Perno, CF; Roveda, A; Simone, MD; Sodani, P | 1 |
Doucette, S; Fergusson, DA; Gill, JS; Jaswal, D; Johnston, O; Knoll, GA | 1 |
Burdick, R; Chaipan, C; Delviks-Frankenberry, KA; Hu, WS; Paprotka, T; Pathak, VK; Venkatachari, NJ | 1 |
Abhyankar, S; Aljitawi, OS; Clough, LA; Divine, CL; Dubois, LK; Ganguly, N; Ganguly, S; Mcguirk, JP; O'Neal, N | 1 |
Anglicheau, D; Bererhi, L; Burgard, M; Legendre, C; Martinez, F; Noel, LH; Pallet, N; Quamouss, O; Rabant, M; Rouzioux, C; Thervet, E | 1 |
Hakeem, A; Sharma, A; Sharma, H | 1 |
Chapman, JR; Craig, JC; Howard, K; Hua, DK; Wong, G | 1 |
Avril, MF; Dallot, A; Di Lucca-Christment, J; Dupin, N; Gressier, L; Jacobelli, S; Laude, H; Morini, JP; Plantier, F; Rosenberg, F; Rozenberg, F | 1 |
Clouser, CL; Greggs, WM; Mansky, LM; Patterson, SE | 1 |
Gao, Y; Momper, JD; Randhawa, PS; Schonder, KS; Shapiro, R; Venkataramanan, R; Zhao, Y | 1 |
Liekens, S | 1 |
Andresen, PA; Bjorang, O; Broch, LU; Midtvedt, K; Scott, H; Tveitan, H | 1 |
Beattie, TJ; Ellis, D; Gonwa, T; Green, MD; Moritz, ML; Saxena, M; Scantlebury, V; Shapiro, R; Singh Randhawa, P; Tuzuner, A; Vats, A | 1 |
Fishman, JA | 1 |
Corey, L; Jerome, KR; Josephson, MA; Kadambi, PV; Limaye, AP; Meehan, SM; Williams, J | 1 |
Bannister, KM; Clarkson, AR; Faull, RJ; Keller, LS; Nolan, J; Peh, CA | 1 |
Abdulkarim, B; Bourhis, J; Deutsch, E; Frascogna, V; Joab, I; Klijanienko, J; Sabri, S; Vainchenker, W; Zelenika, D | 1 |
Ceruse, P; Coulombeau, B; Froehlich, P; Nusa Naiman, A | 1 |
Gangemi, JD; Johnson, JA | 2 |
Milczuk, HA | 1 |
Kaltenis, P | 1 |
Hirsch, HH; Steiger, J | 1 |
Bowden, S; Cooper, JE; Lim, WH; Mathew, TH; Russ, GR | 1 |
Claes, K; Evenepoel, P; Kuypers, DR; Lerut, E; Naesens, L; Snoeck, R; Vandooren, AK; Vanrenterghem, Y | 1 |
Hariharan, S | 1 |
Araya, CE; Dharnidharka, VR; Fennell, RS; Lew, JF; Neiberger, RE | 1 |
Burgos, D; Cabello, M; Florez, P; García, I; Gonzalez-Molina, M; Gutierrez, C; Lopez, J; Lopez, V; Sola, E | 1 |
Balzarini, J; De Clercq, E; Hocková, D; Holý, A; Masojidkova, M; Schols, D; Van Laethem, K | 1 |
Acott, PD; Crocker, JF; Lee, SH; O'Regan, PA | 1 |
Frame, D; Kaul, DR; Levine, JE; Mineishi, S; Newton, D; Savona, MR | 1 |
Andrei, G; De Clercq, E; Fiten, P; Gordts, B; Goubau, P; Opdenakker, G; Selleslag, D; Snoeck, R; van Landuyt, H | 1 |
Gomez, A; Rajpoot, DK; Shanberg, A; Tsang, W | 1 |
Barrios, C; Mir, ML; Puig, JM | 1 |
Akioka, K; Kaihara, S; Nobori, S; Okamoto, M; Ushigome, H; Yoshimura, N | 1 |
de Clercq, E; Fiten, P; Geboes, K; Janssens, J; Opdenakker, G; Rutgeerts, P; Snoeck, R; Van Cutsem, E; Van Ranst, M; Vantrappen, G | 1 |
Balzarini, J; Bischofberger, N; De Clercq, E; Naesens, L | 1 |
De Clercq, E; Neyts, J; Pagano, JS; Raab-Traub, N; Sadler, R | 1 |
Gross, G | 1 |
Hou, J; Major, EO | 1 |
Cockerell, CJ; Zabawski, EJ | 1 |
Delfraissy, JF; Dussaix, E; Gasnault, J; Goujard, C; Karaterki, A; Lannuzel, A; Marchadier, E; Pierre Ferey, M; Taoufik, Y | 1 |
Adriani, B; Beretta, R; Cargnel, A; Fasolo, MM; Orlando, G; Signori, R; Zanchetta, N | 1 |
Bossens, M; De Clercq, E; Muller, C; Noel, JC; Snoeck, R | 1 |
Alberti, PW; Chamberlain, DW; Dancey, DR; Downey, GP; Krajden, M; Palefsky, J | 1 |
Budgeon, LR; Christensen, ND; Kreider, JW; Pickel, MD | 1 |
Beltrame, A; Carosi, G; Casalini, C; Ciravolo, G; Forleo, MA; Graifemberghi, S; Gulletta, M; Matteelli, A; Tedoldi, S | 1 |
Arroyo, JL; Caballero, D; Cañizo, C; de la Loma, A; González-Fraile, MI; Hernández, R; Izarra, A; López, C; Otero, MJ; San Miguel, JF; Vázquez, L | 1 |
Andrei, G; De Clercq, E; Snoeck, R | 1 |
Calista, D | 1 |
Bossens, M; De Clercq, E; Degreef, H; Delaere, B; Jaffe, HS; Noël, JC; Parent, D; Rooney, JF; Snoeck, R; Van Ranst, M; Wulfsohn, MS | 1 |
Clumeck, N; De Clercq, E; De Maubeuge, J; Snoeck, R; Van Laethem, Y | 1 |
Descamps, V; Mahé, E | 1 |
Abdulkarim, B; Bourhis, J; Chagraoui, H; Chouaïb, S; Deutsch, E; Eschwege, F; Maggiorella, L; Sabri, S; Thierry, J; Vainchenker, W | 1 |
Aquaro, S; Balzarini, J; De Clercq, E; Egberink, H; Holý, A; Pannecouque, C; Perno, CF | 1 |
15 review(s) available for organophosphonates and Fibroma, Shope
Article | Year |
---|---|
Treatment of human polyomavirus-7-associated rash and pruritus with topical cidofovir in a lung transplant patient: Case report and literature review.
Topics: Administration, Topical; Adult; Aged; Antiviral Agents; BK Virus; Cidofovir; Cytosine; Exanthema; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Pruritus; Transplant Recipients; Tumor Virus Infections | 2018 |
Comparison of intravenous or intravesical cidofovir in the treatment of BK polyomavirus-associated hemorrhagic cystitis following adult allogeneic stem cell transplantation-A systematic review.
Topics: Administration, Intravenous; Administration, Intravesical; Adult; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Organophosphonates; Polyomavirus Infections; Randomized Controlled Trials as Topic; Treatment Outcome; Tumor Virus Infections; Viral Load | 2018 |
BK virus encephalitis: case report, review of the literature, and description of a novel treatment modality.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cytosine; Encephalitis; Humans; Male; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections | 2013 |
Strategies to prevent BK virus infection in kidney transplant recipients.
Topics: BK Virus; Cytosine; Humans; Immunity, Cellular; Immunity, Humoral; Immunosuppression Therapy; Kidney Transplantation; Organophosphonates; Polyomavirus Infections; Postoperative Complications; Prospective Studies; Quinolones; Transplant Recipients; Tumor Virus Infections | 2016 |
Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Female; Humans; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections | 2008 |
Cidofovir: clinical experience and future perspectives on an acyclic nucleoside phosphonate analog of cytosine in the treatment of refractory and premalignant HPV-associated anal lesions.
Topics: Antiviral Agents; Anus Neoplasms; Cidofovir; Cytosine; Humans; Organophosphonates; Papillomaviridae; Precancerous Conditions; Tumor Virus Infections | 2009 |
Treatment of polyomavirus infection in kidney transplant recipients: a systematic review.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cohort Studies; Creatinine; Cytosine; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Organophosphonates; Polyomavirus Infections; Randomized Controlled Trials as Topic; Reoperation; Survival Rate; Treatment Failure; Tumor Virus Infections; Viremia | 2010 |
The role of growth factors, angiogenic enzymes and apoptosis in neovascularization and tumor growth-collected publications.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cidofovir; Cyclohexanes; Cytosine; Disease Models, Animal; Fibroblast Growth Factor 2; Growth Substances; Hemangioma; Humans; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Organophosphonates; Organophosphorus Compounds; Rats; Sesquiterpenes; Thymidine Phosphorylase; Tumor Virus Infections | 2002 |
[BK virus-associated nephropathy].
Topics: Adult; Age Factors; Antiviral Agents; BK Virus; Child; Cidofovir; Cytosine; Female; Graft Rejection; Humans; Infant; Kidney Diseases; Kidney Transplantation; Male; Organophosphonates; Organophosphorus Compounds; Polyomavirus Infections; Pregnancy; Time Factors; Tumor Virus Infections | 2003 |
Polyomavirus BK.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Humans; Immunocompromised Host; Kidney Diseases; Kidney Transplantation; Organophosphonates; Organophosphorus Compounds; Polyomavirus Infections; Tumor Virus Infections | 2003 |
BK virus nephritis after renal transplantation.
Topics: Antibodies, Viral; Antiviral Agents; BK Virus; Cidofovir; Cytosine; DNA, Viral; Graft Survival; Humans; Immunity, Cellular; Immunosuppressive Agents; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Nephritis; Organophosphonates; Polyomavirus Infections; Prevalence; Risk Factors; Treatment Outcome; Tumor Virus Infections; Viremia | 2006 |
Therapy of human papillomavirus infection and associated epithelial tumors.
Topics: Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; Humans; Imiquimod; Interferon Inducers; Interferons; Laser Therapy; Neoplasms, Glandular and Epithelial; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections; Vaccines, Synthetic | 1997 |
Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
Topics: Administration, Cutaneous; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Herpesviridae Infections; Humans; Injections, Intralesional; Injections, Intravenous; Molluscum Contagiosum; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Sarcoma, Kaposi; Skin Diseases, Viral; Skin Neoplasms; Tumor Virus Infections | 1998 |
Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature.
Topics: Adult; Antiviral Agents; Biopsy; Cidofovir; Cystic Adenomatoid Malformation of Lung, Congenital; Cytosine; Diagnosis, Differential; DNA, Viral; Female; Humans; Laryngeal Neoplasms; Organophosphonates; Organophosphorus Compounds; Papilloma; Papillomaviridae; Papillomavirus Infections; Tomography, X-Ray Computed; Tumor Virus Infections | 2000 |
Cidofovir in the treatment of HPV-associated lesions.
Topics: Administration, Topical; Antiviral Agents; Apoptosis; Cell Division; Cidofovir; Cytosine; Female; Humans; Injections, Intravenous; Male; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections | 2001 |
7 trial(s) available for organophosphonates and Fibroma, Shope
Article | Year |
---|---|
The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients.
Topics: Adult; Aged; Antiviral Agents; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Polyomavirus; Polyomavirus Infections; Treatment Outcome; Tumor Virus Infections | 2009 |
Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir.
Topics: Adolescent; Adult; Anemia, Sickle Cell; BK Virus; Child; Child, Preschool; Cidofovir; Cystitis; Cytosine; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Incidence; Infant; Middle Aged; Organophosphonates; Polyomavirus Infections; Prospective Studies; Thalassemia; Tumor Virus Infections; Young Adult | 2010 |
Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).
Topics: Adult; Antiviral Agents; Biopsy; Cervix Uteri; Cidofovir; Conization; Cytosine; Female; Humans; Immunohistochemistry; Middle Aged; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2000 |
Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons.
Topics: Administration, Cutaneous; Adult; Antiviral Agents; Anus Diseases; Cidofovir; Cytosine; Female; Female Urogenital Diseases; HIV Infections; Humans; Male; Male Urogenital Diseases; Organophosphonates; Organophosphorus Compounds; Patient Satisfaction; Pilot Projects; Single-Blind Method; Treatment Outcome; Tumor Virus Infections; Warts | 2001 |
Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytosine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Molluscum Contagiosum; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Pilot Projects; Recurrence; Severity of Illness Index; Skin Diseases, Viral; Treatment Outcome; Tumor Virus Infections | 2000 |
Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Risk Factors; Treatment Outcome; Tumor Virus Infections | 2001 |
[A new antiviral for genito-anal condylomas].
Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; Double-Blind Method; Female Urogenital Diseases; Humans; Male Urogenital Diseases; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Treatment Outcome; Tumor Virus Infections | 2002 |
63 other study(ies) available for organophosphonates and Fibroma, Shope
Article | Year |
---|---|
Daily low dose intravesical cidofovir for the treatment of BK virus associated hemorrhagic cystitis after allogeneic stem cell transplantation.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Drug-Related Side Effects and Adverse Reactions; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Organophosphonates; Polyomavirus Infections; Renal Insufficiency; Tumor Virus Infections | 2023 |
Successful Treatment of BK Virus Hemorrhagic Cystitis (HC) Post Allogenic Hematopoietic Stem Cell Transplantation with Low Dose Cidofovir.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Male; Organophosphonates; Polyomavirus Infections; Transplantation, Homologous; Tumor Virus Infections | 2017 |
Intravesicular cidofovir for BK hemorrhagic cystitis in pediatric patients after hematopoietic stem cell transplant.
Topics: Administration, Intravesical; Adolescent; Antiviral Agents; BK Virus; Child; Cidofovir; Cystitis; Cytosine; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections | 2018 |
Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Topics: Adult; Antiviral Agents; Biopsy; BK Virus; Cidofovir; Cytosine; Early Diagnosis; Female; Glomerular Filtration Rate; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Diseases; Kidney Transplantation; Logistic Models; Male; Mass Screening; Middle Aged; Multivariate Analysis; Organophosphonates; Polyomavirus Infections; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Texas; Time Factors; Tumor Virus Infections; Viral Load; Viremia; Young Adult | 2013 |
[BK virus infections in pediatric kidney transplant recipients].
Topics: Adolescent; Antiviral Agents; BK Virus; Child; Cidofovir; Cytosine; DNA, Viral; Female; Graft Rejection; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Diseases; Kidney Transplantation; Leflunomide; Male; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections; Turkey | 2013 |
Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cells.
Topics: Animals; Antiviral Agents; Apoptosis; Blotting, Western; Cells, Cultured; Cidofovir; Cyclic AMP; Cytosine; Gammaherpesvirinae; Herpesviridae Infections; Humans; Kidney; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; NIH 3T3 Cells; Organophosphonates; Organophosphorus Compounds; Prodrugs; Tumor Virus Infections; Virus Activation; Virus Replication | 2013 |
Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience.
Topics: Adolescent; Antiviral Agents; BK Virus; Child; Cidofovir; Cystitis; Cytosine; Female; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Male; Organophosphonates; Polyomavirus Infections; Retrospective Studies; Tumor Virus Infections; Viral Load | 2013 |
High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Female; Graft vs Host Disease; Health Care Costs; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Incidence; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Risk Factors; Transplantation, Homologous; Tumor Virus Infections; Viremia; Young Adult | 2014 |
Formulation of cidofovir improves the anti-papillomaviral activity of topical treatments in the CRPV/rabbit model.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Chemistry, Pharmaceutical; Cidofovir; Cottontail rabbit papillomavirus; Cytosine; Excipients; Organophosphonates; Papillomavirus Infections; Rabbits; Treatment Outcome; Tumor Virus Infections | 2014 |
Observations on the use of cidofovir for BK virus infection in renal transplantation.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Retrospective Studies; Tumor Virus Infections; Viral Load; Viremia | 2014 |
Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation.
Topics: BK Virus; Cytomegalovirus Infections; Cytosine; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Kidney Diseases; Male; Middle Aged; Organophosphonates; Polyomavirus; Polyomavirus Infections; Tumor Virus Infections; Viremia | 2015 |
Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation.
Topics: Administration, Intravenous; Adult; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Organophosphonates; Polyomavirus Infections; Retrospective Studies; Time Factors; Transplantation, Homologous; Treatment Outcome; Tumor Virus Infections; Viral Load | 2015 |
Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Drug Administration Schedule; Female; Glomerular Filtration Rate; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Male; Middle Aged; Myeloablative Agonists; Organophosphonates; Polyomavirus Infections; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Tumor Virus Infections; Viral Load | 2016 |
In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Creatinine; Cytosine; Female; Graft Rejection; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Plasma Exchange; Polyomavirus Infections; Prognosis; Risk Factors; Tumor Virus Infections; Viremia | 2016 |
BK polyomavirus encephalitis in a patient with thrombotic microangiopathy after an allogeneic hematopoietic stem cell transplant.
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Antiviral Agents; BK Virus; Cidofovir; Ciprofloxacin; Cystitis; Cytosine; Encephalitis; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hematuria; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Magnetic Resonance Imaging; Middle Aged; Organophosphonates; Polyomavirus Infections; Thrombotic Microangiopathies; Tomography, X-Ray Computed; Transplantation, Homologous; Tumor Virus Infections; Virus Activation | 2016 |
Reduced cell viability and apoptosis induction in human thyroid carcinoma and mesothelioma cells exposed to cidofovir.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cidofovir; Cytosine; DNA Fragmentation; Female; Humans; Mesothelioma; Organophosphonates; Papillomavirus Infections; Polyomavirus Infections; Thyroid Neoplasms; Tumor Virus Infections; Uterine Cervical Neoplasms | 2017 |
Hyperbaric oxygen therapy in BKV-associated hemorrhagic cystitis refractory to intravenous and intravesical cidofovir: case report and review of literature.
Topics: Administration, Intravesical; Adult; Antineoplastic Agents; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytomegalovirus Infections; Cytosine; Hematopoietic Stem Cell Transplantation; Hematuria; Humans; Hyperbaric Oxygenation; Leukemia, Myeloid, Acute; Male; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections | 2009 |
Intravenous immunoglobulin as rescue therapy for BK virus nephropathy.
Topics: Antiviral Agents; BK Virus; Child, Preschool; Cidofovir; Creatinine; Cytosine; Ganciclovir; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Kidney; Kidney Transplantation; Male; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections | 2009 |
Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cytosine; DNA, Viral; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Polyomavirus Infections; Tumor Virus Infections | 2008 |
A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients.
Topics: Adult; Aged; Antiviral Agents; BK Virus; Cidofovir; Cytosine; Female; Humans; Male; Middle Aged; Nephritis, Interstitial; Organophosphonates; Polyomavirus Infections; Transplantation; Transplantation, Homologous; Tumor Virus Infections | 2009 |
Low dosage cidofovir without probenecid as treatment for BK virus hamorrhagic cystitis after hemopoietic stem cell transplant.
Topics: Adolescent; Antiviral Agents; BK Virus; Child; Child, Preschool; Cidofovir; Cystitis; Cytosine; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Organophosphonates; Polyomavirus Infections; Probenecid; Tumor Virus Infections | 2009 |
Intravenous immunoglobulin as treatment for BK virus: nephropathy.
Topics: BK Virus; Cidofovir; Cytosine; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Kidney; Kidney Transplantation; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections | 2009 |
Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study.
Topics: Adolescent; Adult; Antiviral Agents; BK Virus; Child; Child, Preschool; Cidofovir; Cystitis; Cytosine; Female; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Retrospective Studies; Survival Analysis; Treatment Outcome; Tumor Virus Infections; Young Adult | 2009 |
Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.
Topics: Adenine; Animals; Antiviral Agents; Cell Line, Tumor; Cytidine Deaminase; Gammaretrovirus; Humans; Leukemia Virus, Murine; Male; Mice; Mutation; Organophosphonates; Prostatic Neoplasms; Pyrrolidinones; Raltegravir Potassium; Retroviridae Infections; Tenofovir; Tumor Virus Infections; Zidovudine | 2010 |
Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach.
Topics: Adult; Aged; Algorithms; Antiviral Agents; BK Virus; Cidofovir; Cytosine; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Retrospective Studies; Transplantation, Homologous; Tumor Virus Infections | 2010 |
Cidofovir may be deleterious in BK virus-associated nephropathy.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Graft Survival; Humans; Kidney Diseases; Kidney Transplantation; Organophosphonates; Polyomavirus Infections; Treatment Outcome; Tumor Virus Infections | 2010 |
Cidofovir may be deleterious in BK virus-associated nephropathy.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Kidney Diseases; Kidney Transplantation; Organophosphonates; Polyomavirus Infections; Retrospective Studies; Tumor Virus Infections | 2011 |
Cost-effectiveness of cidofovir treatment of polyomavirus nephropathy in kidney transplant recipients.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cost-Benefit Analysis; Cytosine; Decision Support Techniques; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Markov Chains; Middle Aged; Models, Economic; Models, Statistical; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections | 2012 |
Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; Condylomata Acuminata; Cytosine; Diagnosis, Differential; Female; Foscarnet; Humans; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Thalidomide; Treatment Outcome; Tumor Virus Infections | 2012 |
Discovery of drugs that possess activity against feline leukemia virus.
Topics: Adenine; Animals; Antiviral Agents; Azacitidine; Cat Diseases; Cats; Decitabine; Deoxycytidine; Dose-Response Relationship, Drug; Gemcitabine; Leukemia Virus, Feline; Leukemia, Feline; Organophosphonates; Pyrrolidinones; Raltegravir Potassium; Retroviridae Infections; Tenofovir; Tumor Virus Infections | 2012 |
Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antiviral Agents; Area Under Curve; BK Virus; Cidofovir; Cross-Over Studies; Cytosine; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Half-Life; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Probenecid; Tumor Virus Infections; Viremia | 2013 |
Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cytosine; Female; Humans; Injections, Intravenous; Kidney Transplantation; Organophosphonates; Organophosphorus Compounds; Polyomavirus Infections; Tumor Virus Infections | 2002 |
Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults.
Topics: Adult; Antiviral Agents; BK Virus; Child; Child, Preschool; Cidofovir; Cytosine; Female; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polyomavirus Infections; Prospective Studies; Tumor Virus Infections; Viral Load | 2003 |
BK nephropathy: what is the role of antiviral therapy?
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Graft Rejection; Humans; Immunocompromised Host; Kidney Transplantation; Nephritis; Organophosphonates; Organophosphorus Compounds; Polyomavirus Infections; Treatment Outcome; Tumor Virus Infections; Viral Load; Virus Replication | 2003 |
Treatment of refractory BK virus-associated nephropathy with cidofovir.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Creatinine; Cytosine; Diabetes Mellitus, Type 1; Glomerulosclerosis, Focal Segmental; Hispanic or Latino; Humans; Immunosuppression Therapy; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Nephritis; Organophosphonates; Organophosphorus Compounds; Polyomavirus Infections; Treatment Outcome; Tumor Virus Infections; Viral Load; White People | 2003 |
BK transplant nephropathy successfully treated with cidofovir.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Humans; Kidney Transplantation; Male; Middle Aged; Nephritis, Interstitial; Organophosphonates; Organophosphorus Compounds; Polyomavirus Infections; Tumor Virus Infections | 2003 |
Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Topics: Animals; Antiviral Agents; Apoptosis; bcl-2-Associated X Protein; Burkitt Lymphoma; Carcinoma; Caspase 3; Caspase 9; Caspases; Cell Division; Cidofovir; Combined Modality Therapy; Cytosine; Enzyme Activation; Epstein-Barr Virus Infections; Female; Gene Expression Regulation, Viral; Genes, bcl-2; Herpesvirus 4, Human; Humans; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Oncogene Proteins, Viral; Organophosphonates; Organophosphorus Compounds; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; Remission Induction; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Virus Infections; Viral Matrix Proteins; Xenograft Model Antitumor Assays | 2003 |
[Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis].
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Combined Modality Therapy; Cytosine; Female; Follow-Up Studies; Humans; Infant; Injections, Intralesional; Laryngeal Neoplasms; Laryngoscopy; Laser Therapy; Male; Middle Aged; Neoadjuvant Therapy; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Prospective Studies; Treatment Outcome; Tumor Virus Infections | 2002 |
Alpha interferon augments cidofovir's antiviral and antiproliferative activities.
Topics: Antiviral Agents; Blotting, Western; Cell Line, Transformed; Cidofovir; Colony Count, Microbial; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytosine; Drug Synergism; Humans; Interferon-alpha; Keratinocytes; Oncogene Proteins, Viral; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus E7 Proteins; Papillomavirus Infections; Repressor Proteins; Retinoblastoma Protein; Tumor Suppressor Protein p53; Tumor Virus Infections | 2003 |
Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children.
Topics: Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytosine; Female; Humans; Infant; Injections, Intralesional; Laryngeal Neoplasms; Male; Organophosphonates; Organophosphorus Compounds; Papilloma; Papillomaviridae; Papillomavirus Infections; Prospective Studies; Recurrence; Tumor Virus Infections | 2003 |
Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Female; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polyomavirus Infections; Transplantation, Homologous; Tumor Virus Infections | 2003 |
Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients.
Topics: Adult; Aged; Antiviral Agents; BK Virus; Chemotherapy, Adjuvant; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Nephritis, Interstitial; Organophosphonates; Polyomavirus Infections; Treatment Outcome; Tumor Virus Infections | 2005 |
Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.
Topics: Adult; Antiviral Agents; Biopsy; BK Virus; Child; Cidofovir; Contraindications; Cytosine; DNA, Viral; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Kidney Transplantation; Nephritis, Interstitial; Organophosphonates; Polyomavirus Infections; Probenecid; Transplantation, Homologous; Tumor Virus Infections; Uricosuric Agents | 2006 |
Anterior uveitis associated with treatment with intravenous cidofovir in kidney transplant patients with BK virus nephropathy.
Topics: Adult; Aged; Antiviral Agents; BK Virus; Cidofovir; Creatinine; Cytosine; Female; Graft Survival; Humans; Infusions, Intravenous; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Postoperative Complications; Retrospective Studies; Tumor Virus Infections; Uveitis, Anterior | 2006 |
Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines.
Topics: Adenine; Animals; Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV-1; HIV-2; Humans; Mice; Moloney murine sarcoma virus; Organophosphonates; Pyrimidines; Retroviridae Infections; Sarcoma, Experimental; Structure-Activity Relationship; Tenofovir; Tumor Virus Infections | 2007 |
Utilization of vero cells for primary and chronic BK virus infection.
Topics: Animals; Antiviral Agents; BK Virus; Child; Chlorocebus aethiops; Cidofovir; Cytosine; Humans; Models, Biological; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections; Vero Cells | 2006 |
Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant.
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Female; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Male; Medical Records; Middle Aged; Organophosphonates; Polyomavirus Infections; Treatment Outcome; Tumor Virus Infections | 2007 |
Dual infection with polyomavirus BK and acyclovir-resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipient.
Topics: Acyclovir; Adolescent; Antiviral Agents; BK Virus; Bone Marrow Transplantation; Cidofovir; Cytosine; Drug Resistance, Viral; Female; Herpes Simplex; Herpesvirus 1, Human; Humans; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections | 2007 |
Ureteric and urethral stenosis: a complication of BK virus infection in a pediatric renal transplant patient.
Topics: Adolescent; Antiviral Agents; Biopsy; BK Virus; Cidofovir; Cystoscopy; Cytosine; Diagnosis, Differential; DNA, Viral; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Kidney Failure, Chronic; Kidney Transplantation; Male; Microscopy, Electron; Organophosphonates; Polyomavirus Infections; Retrospective Studies; Tumor Virus Infections; Ureteral Obstruction; Urethral Stricture | 2007 |
[Diagnosis of interstitial nephropathy caused by BK virus in renal transplantation. Therapeutic management with cidofovir plus probenecid].
Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cytosine; Drug Therapy, Combination; Humans; Kidney Transplantation; Male; Nephritis, Interstitial; Organophosphonates; Polyomavirus Infections; Probenecid; Tumor Virus Infections | 2007 |
BK virus-associated nephropathy in a kidney transplant recipient successfully treated with cidofovir, the first case in Japan.
Topics: Antiviral Agents; BK Virus; Cidofovir; Cytosine; Female; Humans; Japan; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Tumor Virus Infections | 2008 |
Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.
Topics: Aged; Antiviral Agents; Cidofovir; Cytosine; Esophageal Neoplasms; Female; Humans; Hypopharyngeal Neoplasms; Organophosphonates; Organophosphorus Compounds; Papilloma; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Tumor Virus Infections | 1995 |
Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
Topics: Adenine; Animals; Anti-HIV Agents; Antiviral Agents; Female; Friend murine leukemia virus; Humans; In Vitro Techniques; Leukemia, Experimental; Mice; Mice, Inbred Strains; Mice, SCID; Moloney murine sarcoma virus; Organophosphonates; Prodrugs; Rats; Retroviridae; Retroviridae Infections; Sarcoma, Experimental; Tumor Virus Infections | 1996 |
The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice.
Topics: Adolescent; Animals; Antiviral Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Screening Assays, Antitumor; Female; Ganciclovir; Genes, p53; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Injections, Intralesional; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Organophosphonates; Organophosphorus Compounds; Tumor Virus Infections | 1998 |
The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line.
Topics: Anti-HIV Agents; Antiviral Agents; Brain; Cells, Cultured; Cidofovir; Cytarabine; Cytosine; DNA, Viral; Enzyme Inhibitors; Fetus; Humans; JC Virus; Neurons; Nucleosides; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Topotecan; Tumor Virus Infections; Virus Replication; Zidovudine | 1998 |
Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.
Topics: AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytosine; DNA Primers; DNA Probes; DNA, Viral; Female; HIV-1; Humans; JC Virus; Male; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; Statistics, Nonparametric; Tumor Virus Infections; Viral Load | 1998 |
Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
Topics: Antiviral Agents; Cell Cycle; Cell Transformation, Viral; Cells, Cultured; Cidofovir; Cytosine; Humans; Keratinocytes; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections | 1999 |
Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; DNA, Viral; HIV; Humans; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Recurrence; Tumor Virus Infections; Viral Load | 1999 |
In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas.
Topics: Animals; Antiviral Agents; Cidofovir; Cottontail rabbit papillomavirus; Cytosine; Disease Models, Animal; Humans; Nucleosides; Organophosphonates; Organophosphorus Compounds; Papilloma; Papillomavirus Infections; Rabbits; Treatment Outcome; Tumor Virus Infections | 2000 |
Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis.
Topics: Adolescent; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Cystitis; Cytosine; Hemorrhage; Humans; Male; Organophosphonates; Organophosphorus Compounds; Polyomavirus; Polyomavirus Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; Tumor Virus Infections | 2001 |
Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Antiviral Agents; Bowen's Disease; Cidofovir; Cytosine; Homosexuality, Male; Humans; Male; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Penile Neoplasms; Skin Neoplasms; Tumor Virus Infections | 2001 |
Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
Topics: Animals; Antiviral Agents; Carcinoma; Cell Division; Cidofovir; Cyclin A; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytosine; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Oncogene Proteins, Viral; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Radiation-Sensitizing Agents; Radiation, Ionizing; Retinoblastoma Protein; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2002 |
Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates.
Topics: Animals; Animals, Newborn; Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV-1; Humans; Mice; Mutation; Organophosphonates; Pyrimidine Nucleotides; Tumor Virus Infections | 2002 |